OpenScholar

Search results

267 results found

Author Correction: Mitochondrial metabolism promotes adaptation to proteotoxic stress

Publication: Journal Article

Tsvetkov, P., A. Detappe, K. Cai, H. R. Keys, Z. Brune, W. Ying, P. Thiru, et al. 2019. “Author Correction: Mitochondrial Metabolism Promotes Adaptation to Proteotoxic Stress”. Nat Chem Biol 15: 757.

Genomic Correlate of Exceptional Erlotinib Response in Head and Neck Squamous Cell Carcinoma

Publication: Journal Article

Van Allen, E. M., V. W. Lui, A. M. Egloff, E. M. Goetz, H. Li, J. T. Johnson, U. Duvvuri, et al. 2015. “Genomic Correlate of Exceptional Erlotinib Response in Head and Neck Squamous Cell Carcinoma”. JAMA Oncol 1: 238-44.

Decoupling genetics, lineages, and microenvironment in IDH-mutant gliomas by single-cell RNA-seq

Publication: Journal Article

Venteicher, A. S., I. Tirosh, C. Hebert, K. Yizhak, C. Neftel, M. G. Filbin, V. Hovestadt, et al. 2017. “Decoupling Genetics, Lineages, and Microenvironment in IDH-Mutant Gliomas by Single-Cell RNA-Seq”. Science 355.

SF3B1 and other novel cancer genes in chronic lymphocytic leukemia

Publication: Journal Article

Wang, L., M. S. Lawrence, Y. Wan, P. Stojanov, C. Sougnez, K. Stevenson, L. Werner, et al. 2011. “SF3B1 and Other Novel Cancer Genes in Chronic Lymphocytic Leukemia”. N Engl J Med 365: 2497-506.

Identification of prostate cancer modifier pathways using parental strain expression mapping

Publication: Journal Article

Xu, Q., P. K. Majumder, K. Ross, Y. Shim, T. R. Golub, M. Loda, and W. R. Sellers. 2007. “Identification of Prostate Cancer Modifier Pathways Using Parental Strain Expression Mapping”. Proc Natl Acad Sci U S A 104: 17771-6.

Vignesh Shanmugam

Person: Postdoctoral Fellow

I am a hematopathologist with interests in applying single cell and tissue imaging technologies to better understand the biology of lymphoid malignancies and develop new diagnostic approaches.

Mounica Vallurupalli

Person: Postdoctoral Fellow

I am a physician-scientist interested in functional genomics, transcriptional regulation and myeloid disease biology.

An erythroid differentiation signature predicts response to lenalidomide in myelodysplastic syndrome

Publication: Journal Article

Ebert, B. L., N. Galili, P. Tamayo, J. Bosco, R. Mak, J. Pretz, S. Tanguturi, et al. 2008. “An Erythroid Differentiation Signature Predicts Response to Lenalidomide in Myelodysplastic Syndrome”. PLoS Med 5: e35.

Cas9 activates the p53 pathway and selects for p53-inactivating mutations

Publication: Journal Article

Enache, O. M., V. Rendo, M. Abdusamad, D. Lam, D. Davison, S. Pal, N. Currimjee, et al. 2020. “Cas9 Activates the P53 Pathway and Selects for P53-Inactivating Mutations”. Nat Genet 52: 662-68.

Author Correction: Cas9 activates the p53 pathway and selects for p53-inactivating mutations

Publication: Journal Article

Enache, O. M., V. Rendo, M. Abdusamad, D. Lam, D. Davison, S. Pal, N. Currimjee, et al. 2020. “Author Correction: Cas9 Activates the P53 Pathway and Selects for P53-Inactivating Mutations”. Nat Genet 52: 748-49.